A phenylalanine cluster at the GPER active site is essential for GPER recognition by its agonists and antagonists and this molecular scaffold is proposed to be the binding site of some synthetic tetrahydroquinoline derivatives that inhibit the proliferation of human renal, liver, and pancreatic cancer cell lines in vitro [150]. The gene discussed is GPER1; the disease is pancreatic neoplasm.